System | Type | Disorder | Pubmed |
cancer | | |  |
may serve as an attractive therapeutic tool for cancer |
immunology | inflammatory | |  |
may serve as an attractive therapeutic tool for human renal inflammation related diseases |
diabete | | |  |
activation of both NR1H4 and GPBAR1 may represent an effective therapy for managing diabetes |
obesity | | |  |
activation of both NR1H4 and GPBAR1 may represent an effective therapy for managing obesity |
digestive | liver | steatosis |  |
activation of both NR1H4 and GPBAR1 may represent an effective therapy for managing hepatic steatosis, obesity, and diabetes |
miscelleaneous | urinary | |  |
NR1H4 and GPBAR1 agonists play an important role in preventing progression of kidney disease, atherosclerosis, and vascular calcification |